Anhui Anke BioTech Group (300009) — Financial Flexibility Index
Anhui Anke BioTech Group (300009) has a Financial Flexibility Index of 0.35x as of September 2025. Free cash flow of CN¥262.14 Million (operating CF CN¥240.51 Million minus capex CN¥21.63 Million) represents 0% of total liabilities (CN¥755.64 Million). Also explore 300009 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Anhui Anke BioTech Group Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Anhui Anke BioTech Group across 19 annual periods. Check asset allocation strategy of Anhui Anke BioTech Group to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Anhui Anke BioTech Group (2006–2024)
Year-by-year free cash flow to debt coverage for Anhui Anke BioTech Group. For the full company profile including market capitalisation, see Anhui Anke BioTech Group market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.96x | CN¥802.60 Million | CN¥685.37 Million | CN¥835.41 Million | ▼ -17.1% |
| 2023 | 1.16x | CN¥1.18 Billion | CN¥985.01 Million | CN¥1.02 Billion | ▼ -15.7% |
| 2022 | 1.37x | CN¥1.17 Billion | CN¥698.98 Million | CN¥853.62 Million | ▲ +45.5% |
| 2021 | 0.94x | CN¥723.40 Million | CN¥592.17 Million | CN¥765.52 Million | ▼ -9.7% |
| 2020 | 1.05x | CN¥603.32 Million | CN¥464.80 Million | CN¥576.29 Million | ▲ +14.3% |
| 2019 | 0.92x | CN¥482.10 Million | CN¥295.63 Million | CN¥526.19 Million | ▼ -5.7% |
| 2018 | 0.97x | CN¥501.21 Million | CN¥287.49 Million | CN¥515.86 Million | ▲ +16.3% |
| 2017 | 0.84x | CN¥412.40 Million | CN¥280.63 Million | CN¥493.73 Million | ▲ +37.6% |
| 2016 | 0.61x | CN¥327.18 Million | CN¥258.01 Million | CN¥539.04 Million | ▼ -46.7% |
| 2015 | 1.14x | CN¥155.69 Million | CN¥118.73 Million | CN¥136.82 Million | ▼ -17.8% |
| 2014 | 1.38x | CN¥196.72 Million | CN¥108.68 Million | CN¥142.11 Million | ▲ +45.6% |
| 2013 | 0.95x | CN¥84.85 Million | CN¥53.21 Million | CN¥89.21 Million | ▼ -38.8% |
| 2012 | 1.55x | CN¥113.22 Million | CN¥53.80 Million | CN¥72.91 Million | ▲ +3.5% |
| 2011 | 1.50x | CN¥89.72 Million | CN¥7.18 Million | CN¥59.77 Million | ▲ +72.2% |
| 2010 | 0.87x | CN¥58.61 Million | CN¥47.43 Million | CN¥67.25 Million | ▼ -20.1% |
| 2009 | 1.09x | CN¥51.21 Million | CN¥38.67 Million | CN¥46.95 Million | ▲ +148.9% |
| 2008 | 0.44x | CN¥32.57 Million | CN¥26.04 Million | CN¥74.32 Million | ▼ -1.9% |
| 2007 | 0.45x | CN¥44.42 Million | CN¥35.10 Million | CN¥99.46 Million | ▲ +43.7% |
| 2006 | 0.31x | CN¥32.24 Million | CN¥29.66 Million | CN¥103.72 Million | — |